Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Jemincare group has completed the Phase I clinical trial of its anti-SARS-CoV-2 neutralizing antibody JMB2002
2021-09-14 11:43
Gates Foundation's Annual Goalkeepers Report Finds Stark Disparities in COVID-19 Impacts
2021-09-14 11:00
RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval
2021-09-13 19:00
Winners of HK$1 million in prizes including a Tesla Model 3 in the Goodman #goodshot Vaccination Lucky Draw announced
2021-09-10 20:06
3DMed Diagnostics Donates Medical Supplies to Support COVID-19 Fight in Cambodia
2021-09-10 18:22
Whiz Gambit now available across EMEA
2021-09-10 11:00
DiaCarta Receives CE/IVD for its New COVID 19 Screening Test that Identifies Delta Plus and New Variants
2021-09-10 02:02
Biokangtai: Recombinant COVID-19 Vaccine(Adenovirus Vector) licensed for manufacturing, which actively promotes vaccine export and improves vaccine accessibility
2021-09-09 11:40
Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza
2021-09-08 20:30
Bactiguard appoints new CEO
2021-09-08 09:51
Further Study in humans shows that the DTH response, the basis for CoviDTH, is highly durable and persists for at least one year after COVID-19 exposure or vaccine administration
2021-09-07 20:00
Brii Biosciences Adds US$100 Million to Advance its Late-Stage Monoclonal Antibody Combination Therapy, BRII-196/BRII-198, for Non-Hospitalized COVID-19 Patients
2021-09-07 19:04
Abu Dhabi Welcomes All Vaccinated Travellers from Around the World, Lifting Quarantine Measures starting 5 September 2021
2021-09-03 22:06
BGI safeguards Ethiopia-China Route with airport COVID-19 testing lab
2021-09-03 21:16
PolyU's research finds contact tracing is an effective way for controlling the spread of COVID-19 when borders reopen
2021-09-01 21:12
Phase 1 of the Vaccination Lucky Draw Sponsored by Ng Teng Fong Charitable Foundation and Chinese Estates Closes with Over 2.5 Million Registrations
2021-09-01 20:27
6 Interesting Places in the Philippines Worth Seeing After Pandemic
2021-08-31 19:33
Organ transplants fell by a third worldwide during first wave of COVID-19 pandemic, new study presented at ESOT Congress 2021 shows
2021-08-31 07:01
Kenya Grants Emergency Use Authorization for the INDICAID(TM) COVID-19 Rapid Antigen Test
2021-08-30 09:00
INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800
2021-08-26 20:00
1
25
26
27
28
29
91